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Abstract
a-Synuclein is highly associated with some neurodegeneration and malignancies. Overexpressing wild-type or mutant a-
synuclein promotes neuronal death by mitochondrial dysfunction, the underlying mechanisms of which remain poorly
defined. It was recently reported that a-synuclein expression could directly lead to mitochondrial fragmentation in vitro and
in vivo, which may be due to a-synuclein localization on mitochondria. Here, we applied a double staining method to
demonstrate mitochondrial morphogenetic changes in cells overexpressed with a-synuclein. We show that mitochondrial
localization of a-synuclein was increased following its overexpression in three distinct cell lines, including HeLa, SH-SY5Y,
and PC12 cells, but no alteration in mitochondrial morphology was detected. However, a-synuclein knockdown prevents
MPP
+-induced mitochondrial fragmentation in SH-SY5Y and PC12 cells. These data suggest that a-synuclein protein levels
hardly affect mitochondrial morphology in normal cell lines, but may have some influence on that under certain
environmental conditions.
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Introduction
a-Synuclein is a small and natively unfolded protein, and it is
the first member of synuclein family which is named as earlier
studies showed that a-synuclein only localizes in presynaptic
terminals and nucleus [1]. Yet later, a-synuclein was shown in the
somata of specific neuronal populations in the rat brain, e.g. in the
SNpc, using a monoclonal antibody [2]. a-Synuclein has attracted
considerable attention due to its involvement in neurodegenerative
diseases, such as Parkinson’s disease (PD) and Alzheimer’s disease
[3,4,5]. Beyond those, aberrant expression of a-synuclein may be
highly associated with human malignancies [6,7]. However, less is
known about its normal function.
Several studies already noticed some connection between a-
synuclein and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
(MPTP), a well characterized neurotoxin for inducing PD models
at present, which oxidized in vivo into the toxic substrate 1-
methyl-4-phenylpyridinium (MPP
+) [8,9,10]. Vila et al. found that
MPTP enhances a-synuclein expression in vivo [11]; Dauer et al.
reported that a-synuclein is required for MPTP-induced apoptosis
as a-synuclein null mice presents striking resistance to MPTP [12].
These studies established a model to link environmental and
genetic factors in PD-like cell death; still, the mechanism
underlying is poorly elucidated.
Lately, a pathogenic link between a-synuclein and mitochondria
was established by the observations that some transgenic mice
overexpressing wild-type or mutant a-synuclein develop abnormal
mitochondrial morphology [13,14,15]. Buttner et al. showed that
depletion of mitochondria DNA in yeast inhibits ROS formation
and cell apoptosis induced by a-synuclein [16], further suggesting
a direct functional connection between a-synuclein and mito-
chondria. More than those, a series of articles indicates that a-
synuclein may directly interact with mitochondria. We reported
that, in addition to its predominantly cytosolic and vesicular
localization, a fraction of a-synuclein localizes in the mitochondria
under physiological condition [17], which is confirmed by many
other studies [18,19]. Nevertheless, the normal function and
pathogenic role of mitochondrial a-synuclein need further
investigation.
Recently, Kamp et al. reported that a-synuclein has an
inhibitory function on membrane fusion, and it binds to
mitochondria and directly leads to mitochondrial fragmentation
when overexpressed in cell cultures and Caenorhabditis elegans
[20]. In addition, Nakamura et al. described that the effect is not
accompanied by changes in the morphology of other organelles,
including endoplasmic reticulum (ER) and lysosomes [21]. This
may reveal a novel model of mitochondrial dynamic regulation,
yet some questions remains unanswered: Since recombinant a-
synuclein induces fission of artificial membranes, why does it have
no influence on other lipid membranes in cells, such as ER and
lysosomes, except mitochondria? Therefore, more direct evidence
is needed to show the role of a-synuclein levels in mitochondrial
morphology.
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e36377Mitochondria and a-synuclein were double-stained in this
study, which not only allows us to compare mitochondrial
morphology and a-synuclein expression and distribution among
three distinct cell lines, including Hela, SH-SY5Y and PC12 cells,
but also to directly assess mitochondrial morphological changes in
cells following a-synuclein overexpression. Our results indicate
that a-synuclein expression levels has little influence on mito-
chondrial morphology in normal cells, but knockdown of a-
synuclein prevents MPP
+-induced mitochondrial fragmentation in
SH-SY5Y and PC12 cells. These data imply that a-synuclein plays
no role in mitochondrial morphology under normal condition, but
may have some effect on that at the presence of certain
environment factors.
Results
Mitochondrial Morphological Characteristics in Cell Lines
Are Hardly Affected by Fixation
To observe the effects of a-synuclein overexpression on
mitochondrial morphology, we need to track down a-synuclein
overexpressed cells. However, some traditional approaches may be
unsuitable for a-synuclein, such as fluorescent protein tags used in
many papers. As a typical natively unfolded protein, a-synuclein
lacks of rigid and ordered structure under physiological conditions
in vitro [22,23], and its structure depends extremely on its
environment and accommodates a number of unrelated confor-
mations, which might affect its functions accordingly [24]. If a-
synuclein was tagged with a fluorescent protein, whose molecular
weight is even bigger than a-synuclein, we could not guarantee
that this would not affect its structure or functions. Similar
problems may remain when a fluorescent protein is co-transfected
as an independent reporter. Another option is to transfect cells
with untagged full length human SNCA cDNA, stain live cells with
MitoTracker, fix them and then process for immunofluorescence
staining of a-synuclein, since MitoTracker Red CMXRos stains
mitochondria in live cells and is well-retained in fixed, permea-
bilized cells.
Mitochondrial length (or aspect ratio) is usually used to assess
mitochondrial morphology in live cells [25,26,27], thus firstly, we
need to test whether mitochondrial length would be affected by
cell fixation. SH-SY5Y, PC12 or Hela cells were stained with
MitoTracker-Red CMXRos and then observed on live cell
imaging system using a 1006objective. Images of the same cells
were taken immediately before and 30 min after fixation with 4%
paraformaldehyde to detect mitochondrial morphogenetic alter-
ations, one image often covers 1–2 SH-SY5Y or Hela cells or 4–8
PC12 cells, and the experiment was carried out five times for each
cell line. As shown in Figure 1, mitochondrial length in SH-SY5Y
cells remained almost the same after fixation for 30 min, and no
excessive mitochondrial fragmentation was observed, suggesting
that mitochondrial morphology in live cells is well reserved by
fixation. Similar results were seen in other two cell lines.
Different Patterns of a-Synuclein Distribution Were
Observed among Cell Lines
Since mitochondrial morphological characteristics are barely
affected by cell fixation, we further processed SH-SY5Y, PC12 or
Hela cells for a-synuclein immunofluorescence after MitoTracker
staining, which would allow us to compare endogenous a-
synuclein expression and distribution among cell lines and assess
mitochondrial morphology at the same time. As shown in
Figure 2A, low levels of a-synuclein were expressed in all three
cell lines, and it does not distribute evenly in cells but in a small
dotted fashion. a-Synuclein distributions were quite different
among cell lines. a-Synuclein was relatively highly enriched in the
nucleus in Hela and SH-SY5Y cells other than in PC12 cells.
Punctate staining of a-synuclein spreaded all over the cytoplasm of
SH-SY5Y and Hela cells, while it was far less dispersed in the
cytoplasm of PC12 cells. Further amplified images demonstrated
clearly that most of cytoplasmic a-synuclein co-localized with
mitochondria in PC12 cells, whereas only a small part of
cytoplasmic a-synuclein reside in mitochondria in SH-SY5Y and
Hela cells. That was also confirmed by cytofluorogram analysis in
Figure 2B, showing that Pearson’s Correlation (PC) coefficient in
PC12 cells was much higher than those in SH-SY5Y and Hela
cells. The results above suggest that most of cytoplasmic a-
synuclein accumulates in mitochondria in PC12 cells. Up to date,
we have not found a similar report in other articles. Since PC12
cell line is from rat pheochromocytoma, whether the peculiar
distribution of a-synuclein plays a key role in pathogenesis of
pheochromocytoma requires further study. However, it provides a
good model to investigate the effects of mitochondria localization
of a-synuclein on mitochondrial morphology, but yet no excessive
mitochondrial fragmentation was observed in PC12 cells when
compared with SH-SY5Y and Hela cells.
a-Synuclein Overexpression does not Directly Influence
Mitochondrial Morphology in Cell Lines
To investigate whether a-synuclein overexpression leads to
mitochondrial fragmentation, SH-SY5Y, PC12 and Hela cells
were transfected with a constructed plasmid expressing human a-
synuclein (SNCA) using FuGENE HD Transfection Reagent.
Firstly, different ratios of plasmid DNA (mg)/transfection reagent
(ml) (1:3, 1:4, 1:5, 1:6) were applied to optimize transfection
efficiency for each cell line. Immunoblotting analysis after
transfection for 48 h showed that 1 mg plasmid DNA/4 ml
transfection reagent already provided the best transfection
efficiency for SH-SY5Y cells (Figure S1), which was then used in
the following experiments. Similar results were seen in PC12 and
Hela cells (data not shown).
After transfection for 48 h, cells overexpressed with a-synuclein
or transfected with an empty vector were both processed for
double-staining of mitochondria and a-synuclein, and then
observed on live cell imaging system using a 1006 objective.
Images of 20 cells from random view fields were taken from each
Figure 1. Cell Fixation Does not Alter Mitochondrial Morphol-
ogy Probed by Staining with MitoTracker-Red CMXRos. A.
Representative images of mitochondria in the same SH-SY5Y cells
stained with MitoTracker-Red CMXRos were taken immediately before
and 30 min after fixation with 4% paraformaldehyde on live cell
imaging system. Mitochondrial morphology in SH-SY5Y cells remains
almost the same after fixation for 30 min. Scale bars for 10 mm. B.
Quantitative analysis of changes in mitochondrial length of the same
SH-SY5Y cells in images taken immediately before and 30 min after
fixation. The experiment was carried out five times, and no perceptible
difference in mitochondrial length is detected in SH-SY5Y cells after
fixation.
doi:10.1371/journal.pone.0036377.g001
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fluorogram analysis, and the experiment was repeated three times.
The expression of a-synuclein was also assayed by immunoblot-
ting. As shown in Figure 3A and C, SH-SY5Y cells transfected
with human SNCA presented a high level of a-synuclein
expression, compared with a pretty low level in the cells
transfected with an empty vector. Representative mitochondrial
images demonstrated no remarkable mitochondrial fragmentation
in a-synuclein overexpressed cells, compared with those in the cells
transfected with an empty vector (Figure 3A). And quantitative
analysis of mitochondrial length also showed no significant
difference between these two groups of cells (vector group:
2.8560.25 vs. SNCA group: 2.8860.31, P.0.05) (Figure 3D).
Similar results were detected when we observed the effects of a-
synuclein overexpression on mitochondrial morphology in PC12
(vector group: 3.6460.29 vs. SNCA group: 3.5560.20, P.0.05)
(Figure 4A and D) and Hela cells (vector group: 4.4160.37 vs.
SNCA group: 4.6860.30, P.0.05) (Figure 5A and D). These data
suggest that it may be a common biological event that simply
raising a-synuclein expression levels would not affect mitochon-
drial morphology directly.
a-Synuclein Overexpression Promotes Its Mitochondrial
Localization without Inducing Mitochondrial
Fragmentation
It is suggested that the mitochondrial fragmentation induced by
a-synuclein overexpression may be due to its localization on
mitochondria [20]. To examine whether a-synuclein localization
on mitochondria was promoted after SNCA transfection in our
experiment, we isolated mitochondria and analyzed mitochondrial
a-synuclein expression by immunoblotting. Mitochondrial or
cytosolic extracts were first examined by immunoblotting for the
presence of cytochrome oxidase subunit IV (COX IV) and b-actin.
A robust band of COX IV was detected from the mitochondrial
extracts, while the b-actin band was pretty weak; they were
opposite in the cytosolic fraction, suggesting that the mitochondrial
fraction was enriched with mitochondria, while few mitochondria
were detected in the cytosolic fraction (Figure S2). a-Synuclein
expression in mitochondrial pellets was very low in SH-SY5Y
(Figure 3C), PC12 (Figure 4C) and Hela cells (Figure 5C), yet it
was remarkably increased in all three cell lines after SNCA
transfection for 48 h.
Representative double-staining images of mitochondria and a-
synuclein demonstrated that after SNCA transfection for 48 h, a-
synuclein expression in all three cell lines was significantly
increased and its distribution was greatly changed compared with
those in the cells transfected with an empty vector. a-Synuclein
was highly enriched in the nucleus in Hela and PC12 cells after
SNCA transfection (Figure 4A and 5A), and its expression was also
strong in the nucleus in SH-SY5Y cells, but even stronger in the
cytoplasm (Figure 3A). a-Synuclein was expressed all over the
cytoplasm in PC12 cells, where some peculiar punctate staining of
a-synuclein was more standout and mostly co-localized with
mitochondria, as shown in the amplified images in Figure S3.
Cytofluorogram analysis of those double-staining images demon-
strated that in all three cell lines, PC coefficients in a-synuclein
overexpressed cells were magnificently elevated compared with the
cells transfected with an empty vector (Figure 3A and B, 4A and B,
5A and B). These indicate that more a-synuclein co-localizes with
mitochondria in a-synuclein overexpressed cells.
Although mitochondrial localization of a-synuclein was in-
creased following SNCA transfection, mitochondria in three cell
lines still remain an elongated tubular and thread-like shape and
no significant change in mitochondrial length was detected
between a-synuclein overexpressed cells and those transfected
with an empty vector (Figure 3A and D, 4A and D, 5A and D).
This indicates that a-synuclein overexpression increases its
localization on mitochondria without affecting mitochondrial
morphology in cell lines.
a-Synuclein Suppression does not Alter Mitochondrial
Morphology, but Prevents Mitochondrial Fragmentation
in Dopaminergic Cell lines Exposed to MPP
+
Since a-synuclein overexpression has no effect on mitochondrial
morphology, we next detected the effects of a-synuclein knock-
down on mitochondrial morphology. SH-SY5Y or PC12 cells
Figure 2. a-Synuclein Distribution Patterns and Mitochondrial
Morphology in Three Cell Lines. A. Representative double-staining
images show the patterns of a-synuclein distribution (green) and
mitochondrial morphology (red) in SH-SY5Y, PC12 and Hela cells. Low
levels of a-synuclein were expressed in all three cell lines, and it
distributes in a small dotted fashion. a-Synuclein is relatively highly
expressed in the nucleus in SH-SY5Y and Hela cells other than in PC12
cells. Amplified images further demonstrate that only a small part of
cytoplasmic immunofluorescent staining of a-synuclein co-localizes
with mitochondria in SH-SY5Y and Hela cells, while most of cytoplasmic
a-synuclein reside in mitochondria in PC12 cells. Scale bars for 10 mm.
B. Cytofluorogram analysis of the double-staining images above shows
that Pearson’s Correlation (PC) coefficient is much higher in PC12 cells
than those in SH-SY5Y and Hela cells. CC, colocalization coefficient.
doi:10.1371/journal.pone.0036377.g002
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negative control sequence, and the expression of a-synuclein was
assayed by immunoblotting. SNCA siRNA provided good
knockdown of a-synuclein, while negative control sequence hardly
affected a-synuclein expression in SH-SY5Y (Figure 6A) or PC12
cells (Figure S4B)after transfection for 2 to 5 d. Mitochondria were
visualized by staining with MitoTracker-Green FM, and images
were taken and analyzed and mitochondrial length was quantified
as described above. There was no perceptible difference in
mitochondrial length between negative group and RNAi group of
SH-SY5Y (Figure 6B and 7) or PC12 cells (Figure S4A and D),
implying that a-synuclein suppression does not affect mitochon-
drial morphology in those two dopaminergic cell lines, either.
Recently, Wang et al. observed mitochondrial fragmentation in
SH-SY5Y cells induced by MPP
+, a dopaminergic neurotoxin
[28]. To probe whether a-synuclein is involved in MPP
+-induced
mitochondrial fragmentation, cell cultures from both groups above
were treated with 1 mM MPP
+ after transfection for 2 d. After
MPP
+ exposure for 24 h and 36 h, mitochondrial morphology
were determined as described above, and apoptotic cells were
determined by flow cytometry. As demonstrated in Figure 6C,
MPP
+ treatment resulted in severe cell damage in the negative
group of SH-SY5Y cells, and the percentage of apoptotic cells
reached 19.2361.90% at 24 h and 28.3160.93% at 36 h.
Nonetheless, cellular injury was prevented remarkably in the
RNAi group of SH-SY5Y cells, where the percentage of apoptotic
cells never reached more that 15% after MPP+ exposure. MPP
+
treatment also led to remarkable mitochondrial fragmentation in
the negative group of SH-SY5Y cells (Figure 7A–C), and
mitochondrial length was significantly decreased by MPP
+
(Figure 6B). However, severe mitochondrial fragmentation was
hardly seen in the RNAi group of SH-SY5Y cells after MPP
+
exposure (Figure 7D–F), and mitochondrial length was much
longer compared with the negative group (Figure 6B). Similar
results were seen in PC12 cells, that a-synuclein suppression by
RNAi attenuated MPP
+-caused mitochondrial fragmentation
(Figure S4A and D) and cell apoptosis (Figure S4C). These
indicate that a-synuclein may not contribute much to retain
normal mitochondrial morphology, yet its suppression resists
MPP
+-induced mitochondrial fragmentation in dopaminergic cell
lines.
Discussion
Mitochondria undergo continuous fission and fusion in living
cells, which is necessary for maintaining mitochondrial network
morphology and physiological functions. Mitochondrial fission
and fusion were first described in yeast [29], and found that it is
mediated by a group of large GTPases [30,31,32,33]. Although
their precise mechanism of action is unclear, the conservation of
these GTPases across species suggests that there are some similar
mechanisms of mitochondrial dynamics between mammalian cells
and yeast [34]. In addition to these GTPases, other proteins have
been implicated in the regulation of mitochondrial fusion and
fission in mammalian cells, however, almost all of them participate
in the regulation of mitochondrial dynamics by interacting with
these GTPases. For example, mitochondria-associated PTEN-
induced kinase 1 (PINK1), a protein linked to familial PD,
regulates mitochondrial dynamics through interaction with the
Figure 3. a-Synuclein overexpression promotes its mitochondrial localization without inducing mitochondrial fragmentation in SH-
SY5Y cells. A. Representative double-staining images of a-synuclein (Green) and mitochondria (Red) in SH-SY5Y cells overexpressed with a-
synuclein (SNCA group) or transfected with an empty vector (Vector group) for 48 h. Amplified images further show that no obvious alteration in
mitochondrial morphology between these two groups. Cytofluorogram analysis demonstrates that PC coefficient is remarkably elevated in a-
synuclein overexpressed cells (PC=0.313104, CC Mx=0.840827, CC My=0.986122) compared with Vector group (PC=0.021315, CC Mx=0.964957,
CC My=0.780582). Scale bars for 10 mm. B. Quantitative analysis demonstrates that PC coefficients are remarkably elevated in SNCA group compared
with Vector group. C. Immunoblotting assay shows that a-synuclein expression levels are significantly elevated in SH-SY5Y cell lysates and
mitochondrial lysates after transfected with SNCA for 48 h (n=4). D. Quantitative analysis of changes in mitochondrial length shows no significant
statistic difference between SNCA group and Vector group. Images of 20 cells from each group were processed for cytofluorogram (B) and
mitochondrial morphology analysis (D), and the experiment was repeated three times. *P,0.05, **P,0.01.
doi:10.1371/journal.pone.0036377.g003
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basis, a-synuclein may not be able to direct mitochondrial fission
or fusion. Although Kamp et al. described that a-synuclein could
inhibit protein-free model membrane fusion in vitro, but the
concentration of a-synuclein in these reactions was much higher
than in normal cells. Therefore, it is difficult to rule out a
possibility that it may be the result of a simple physical action.
a-Synuclein protein is specific to the vertebrate and expresses at
high levels in the brain, especially within developing neurons [36],
suggesting its roles in the development of central nervous system.
Supposing that a-synuclein directly regulates mitochondrial
dynamics, mitochondrial fission/fusion machinery in vertebrate
neurons would be very different from that in other types of cells in
vertebrate or in non vertebrate neurons, yet there is no evidence to
support this hypothesis. When cells become malignant, some of
them, such as Hela cells, start to express a-synuclein while the
normal cells would not [6,7], nonetheless, no data indicate that
excessive mitochondrial fission was found in the malignant cells.
Additionally, mitochondria are shorter in immature cells than in
mature cells [37,38], and mitochondrial fission is essential for
embryonic development. Mice lacking the mitochondrial fission
GTPase Drp1 have developmental abnormalities and die after
embryonic day 12.5 and neural cell-specific Drp1 null mice die
shortly after birth [39]. Although a-synuclein expression levels are
pretty higher in embryos or infants than in adults [40,41], mice
lacking a-synuclein show only subtle abnormalities in neurotrans-
mission [42,43,44], lending an evidence to support that a-
synuclein expression levels may not affect mitochondrial morpho-
genesis directly. Since suppression of a-synuclein has potential
values for therapy of PD and related diseases, it is of great
biological importance that a-synuclein would not play a key role in
essential physiological functions.
In conclusion, our results demonstrate that neither a-synuclein
expression levels nor its localization to mitochondria affects
mitochondrial dynamics. But, this does not mean that a-synuclein
is in no way involved in regulation of mitochondrial dynamics. In
fact, we found that a-synuclein participates in MPP
+ induced
mitochondrial fragmentation, suggesting that environmental risk
factors may be essential for a-synuclein to gain a function to be
involved into mitochondrial dynamics, which required further
studies.
Recently, genetic contributions in PD pathology have received
much attention, but cross-sectional twin studies found that even
within families affected by monogenic PD, the age of onset,
symptoms and end-stage pathology may be quite variable
[45,46,47]. More than that, no obvious connections were found
in PD patients between a-synuclein expression and neuronal
damage. In fact, a-synuclein protein levels are far higher during
early human development than late when PD usually occurs [40],
and a-synuclein mRNA label is strong in both affected and
unaffected neurons in PD [48]. A possible explanation is that
certain environmental exposure is necessary for wild-type a-
synuclein to gain its toxicity in PD patients, and our results may
lend evidences to support the hypothesis.
Materials and Methods
Cell culture
SH-SY5Y, Hela and PC12 cells were obtained from American
Tissue Culture Collection and used within 20 passages of the
Figure 4. a-Synuclein overexpression increases its localization on mitochondria without causing mitochondrial fragmentation in
PC12 cells. A. Representative double-staining images of a-synuclein (Green) and mitochondria (Red) in PC12 cells transfected with SNCA or an
empty vector for 48 h. Amplified images clearly demonstrate that no perceptible alteration in mitochondrial morphology between these two groups.
Cytofluorogram analysis shows that PC coefficient of that a-synuclein overexpressed cell (PC=0.574982, CC Mx=0.972038, CC My=0.98707) is much
higher than Vector group (PC=0.316512, CC Mx=0.962559, CC My=0.439231). Scale bars for 10 mm. B. Quantitative analysis shows that PC
coefficients in SNCA group are remarkably elevated compared with Vector group. C. Immunoblotting assay shows that a-synuclein expression levels
in PC12 cell lysates and mitochondrial lysates are both significantly increased after SNCA transfection for 48 h (n=4). D. Quantitative analysis of
changes in mitochondrial length shows no significant statistic difference between SNCA group and Vector group. Images of 20 cells from each group
were processed for cytofluorogram (B) and mitochondrial morphology analysis (D), and the experiment was repeated three times. *P,0.05, **P,0.01.
doi:10.1371/journal.pone.0036377.g004
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eagle’s medium (DMEM)/F12 medium supplemented with 15%
fetal bovine serum (FBS), 100 IU/ml penicillin, 0.1 mg/ml
streptomycin and 3.7 g/L NaHCO3. Hela cells were grown in
DMEM medium supplemented with 10% FBS, 100 IU/ml
penicillin, 0.1 mg/ml streptomycin and 3.7 g/L NaHCO3.
PC12 cells were grown in DMEM medium supplemented with
10% horse serum, 5% FBS, 100 IU/ml penicillin, 0.1 mg/ml
streptomycin and 3.7 g/L NaHCO3. Cell cultures were all kept at
37uC in a saturated humidity air atmosphere containing 5% CO2.
Transfection of SNCA
Cells at 50% confluency were transiently transfected using
FuGENE HD Transfection Reagent (Roche) following the
instruction of the manufacturer. Full length human SNCA cDNA
subcloned into pCMV6-XL5 was purchased from Origene.
Plasmid DNA was first diluted in OPTI-MEM I (Gibco-BRL,
USA) and then mixed with FuGENE HD Transfection Reagent.
Following a 20-minute incubation period at room temperature,
the DNA-FuGENE HD Transfection Reagent mixture was added
to the antibiotic-free transfection medium (DMEM containing
Figure 5. a-Synuclein overexpression in Hela cells promotes its co-localization with mitochondria without affecting mitochondrial
morphology. A. Representative double-staining images of a-synuclein (Green) and mitochondria (Red) in Hela cells transfected with SNCA or an
empty vector for 48 h. Further amplified images show that no obvious change in mitochondrial morphology between these two groups.
Cytofluorogram analysis demonstrates that PC coefficient in that a-synuclein overexpressed cell is remarkably elevated (PC=0.374221, CC
Mx=0.998574, CC My=0.845116) compared with Vector group (PC=20.0338751, CC Mx=0.905173, CC My=0.796768). Scale bars for 10 mm. B.
Quantitative analysis demonstrates that PC coefficients in SNCA group are much higher than Vector group. C. Immunoblotting assay demonstrates
that a-synuclein expression levels in Hela cell lysates and mitochondrial lysates are both remarkably increased after SNCA transfection for 48 h (n=4).
D. Quantitative analysis of changes in mitochondrial length shows no significant statistic difference between SNCA group and Vector group. Images
of 20 cells from each group were processed for cytofluorogram (B) and mitochondrial morphology analysis (D), and the experiment was repeated
three times. *P,0.05, **P,0.01.
doi:10.1371/journal.pone.0036377.g005
Figure 6. a-Synuclein knockdown prevents MPP
+-induced cell apoptosis and mitochondrial fragmentation in SH-SY5Y cells. A.
Immunoblotting assay demonstrates that a-synuclein expression is remarkably suppressed in SH-SY5Y cells transfected with SNCA siRNA (RNAi
group) for 2–5 d, yet it is hardly affected in cells transfected with a negative control sequence (Neg group) (n=5). B. Quantitative analysis of changes
in mitochondrial length shows that MPP
+ (1 mM) decreases mitochondrial length in Neg group, however, it has little effect on the index in RNAi
group. Images of 20 cells from each group were processed for mitochondrial morphology analysis, and the experiment was repeated three times. C.
Flow cytometric analysis of cell apoptosis shows that MPP
+ leads to severe cell injury in Neg group, while it slightly harms SH-SY5Y cells in RNAi group
(n=4). *P,0.05, **P,0.01, ***P,0.001 Neg versus RNAi; #P,0.05, ##P,0.01, ###P,0.001 compared with Neg control.
doi:10.1371/journal.pone.0036377.g006
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saturated humidity air atmosphere containing 5% CO2. The
medium was replaced with normal culture medium 6 hours later.
Cells were used for further experiments 48 hours after transfec-
tion.
Transfection of siRNA
Small interfering RNA (siRNA) was Stealth select siRNA
purchased from Invitrogen (Carlsbad, CA). The targeting sense
sequence for human SNCA in SH-SY5Y cells is 59-GACCAAA-
GAGCAAGUGACAAAUGUU-39, and the one for rat SNCA in
PC12 cells is 59-GGGCGUCCUCUAUGUAGGUUCCAAA-39.
Stealth
TM RNAi Negative Control Duplex (Medium GC, Invitro-
gen) was used as a negative control for the RNAi response. They
were all transfected with Lipofectamine RNAi MAX (Invitrogen)
according to the manufacturer’s instructions. Cells were used for
various experiments 48 hours after transfection.
Isolation of mitochondria
We isolated mitochondria from three cell lines according to the
method of Du et al. [49]. Mitochondria were isolated by
centrifuging cell homogenates at 1,500 g for 5 min at 4uC. We
adjusted the supernatant to 14% Percoll and recentrifuged at
12,000 g for 10 min. The supernatant was subjected to further
centrifugation at 15,000 g for 20 min at 4uC, with the resultant
supernatant being used as the cytosolic fraction. The loose
mitochondrial pellet was resuspended and recentrifuged at
8000 g for 10 min. Highly purified mitochondria were used for
immunoblotting assay.
Apoptosis analysis
Detection of apoptosis by flow cytometry (FACScan; BD
Company) was performed using the Annexin V-FITC apoptosis
detection kit (BD Company) according to the manufacturer’s
instructions. A minimum of 10,000 cells were analyzed in each
treatment.
Western blotting analyses
Cells were collected after transfection for 48 hours. Cell lysates
or mitochondrial lysates were prepared and ran on 10%–12%
SDS-PAGE gels. Antibodies used were as follows: rabbit
polyclonal anti-a-synuclein (1:1,000, Cell signaling), rabbit anti-
sera against COX IV (1:1500, Cell signaling), mouse antibody
against b-actin (1:20,000, Sigma).
Mitochondrial morphology assessment of fixed cells
Cells were plated in glass-bottom culture dishes for mitochon-
drial observation. After SNCA transfection for 48 hours, mito-
chondria were visualized by staining with MitoTracker-Red
CMXRos (Molecular Probes) at a final concentration of 50 nM
and cells were then processed for immunofluorescence as
described below. Images of 20 cells from random view fields were
taken from each group on UltraView VoX 3D live cell imaging
system (PerkinElmer) using a 1006objective, Z-stacks were taken
at 0.5 mm intervals, and the experiment was repeated three times.
Cell images were analyzed for lengths of major and minor axes of
the ellipse equivalent to the mitochondrion using Volocity 5.0
(Improvision, Lexington, MA) software. From these values, we
calculated mitochondrial length (or aspect ratio, the ratio between
the major and minor axes of the ellipse equivalent to the
mitochondrion) [25,26,27]. Mitochondrial aspect ratio has a
minimal value of 1 when it is a perfect circle and the value
elevates when mitochondria become elongated.
Mitochondrial morphology assessment of live cells
SH-SY5Y or PC12 cells were plated in glass-bottom culture
dishes for mitochondrial observation on live cell imaging system.
Mitochondria were visualized by staining with MitoTracker-
Green FM or MitoTracker-Red CMXRos (Molecular Probes),
both at a final concentration of 50 nM, or by transfection with a
mitochondria-targeted GFP (Molecular Probes) according to the
manufacturer’s instructions. Images were taken and analyzed and
mitochondrial length was quantified as described above.
Immunofluorescence
Cells were rinsed with pre-warmed PBS (pH 7.2) and fixed in
4% paraformaldehyde for 30 min. After washed with PBS for 3
times, cells were permeabilized with 0.2% Triton X-100 for
30 min, and incubated with 10% fetal calf serum for 90 min. To
determine a-synuclein-immunoreactive cells in culture, cells were
sequentially incubated with rabbit polyclonal anti-a-synuclein
primary antibody (Millipore) for 2 hours and FTIC-conjugated
anti-rabbit IgG (Rockland) for 90 min, and washed with PBS
between stages. Each step above was carried out at room
temperature.
Figure 7. The effects of a-synuclein suppression on mitochon-
drial morphology in SH-SY5Y cells. Representative images taken
by live cell imaging system show no obvious alteration in mitochondrial
morphology between Neg group (A) and RNAi group (D). MPP
+ (1 mM)
induces severe mitochondrial fragmentation in Neg group (B and C) but
has little effect on mitochondrial morphology in RNAi group (E and F).
Scale bar for 10 mm.
doi:10.1371/journal.pone.0036377.g007
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The data are expressed as means 6 SE and were subjected to
statistical analysis via one-way ANOVA or non-paired, two-tailed
Student’s t-test. The level of statistical significance was set at
P,0.05.
Supporting Information
Figure S1 Transfection efficiency of human a-synuclein
in SH-SY5Y cells. Different ratios of plasmid DNA (mg)/
transfection reagent (ml) (1:3, 1:4, 1:5, 1:6) were applied to SH-
SY5Y cells to optimize transfection efficiency. Immunoblotting
analysis after transfection for 48 h showed that 1:4, 1:5 and 1:6 of
plasmid DNA/transfection reagent provided the best transfection
efficiency for SH-SY5Y cells. *P,0.05, **P,0.01 compared with
control.
(TIF)
Figure S2 Mitochondrial preparation confirmation.
Cytosolic and mitochondrial extracts were both examined by
immunoblotting for the presence of cytochrome oxidase subunit
IV (COX IV) and b-actin. Representative immunoblotting image
shows that mitochondrial fraction was enriched with mitochon-
drial marker COX IV, while few mitochondria were detected in
cytosolic fraction.
(TIF)
Figure S3 a-Synuclein overexpression promotes its
mitochondrial localization in PC12 cells. Further amplified
images of Figure 4A demonstrate that a-synuclein overexpression
increases its mitochondrial localization in PC12 cells.
(TIF)
Figure S4 a-Synuclein knockdown prevents MPP
+-in-
duced cell apoptosis and mitochondrial fragmentation
in PC12 cells. A. Representative images taken by live cell
imaging system show no obvious alteration in mitochondrial
morphology between Neg group and RNAi group. MPP
+ (1 mM)
induces severe mitochondrial fragmentation in Neg group but has
little effect on mitochondrial morphology in RNAi group. Scale
bar for 10 mm. B. Immunoblotting assay demonstrates that a-
synuclein expression is remarkably suppressed in PC12 cells
transfected with SNCA siRNA (RNAi group) for 2–5 d, yet it is
hardly affected in cells transfected with a negative control
sequence (Neg group) (n=5). C. Flow cytometric analysis of cell
apoptosis shows that MPP
+ leads to severe cell injury in Neg
group, while it slightly harms PC12 cells in RNAi group (n=4). D.
Quantitative analysis of changes in mitochondrial length shows
that MPP
+ reduces mitochondrial length in Neg group, whereas it
has little effect on the index in RNAi group. Images of 20 cells
from each group were processed for mitochondrial morphology
analysis, and the experiment was repeated three times. *P,0.05,
**P,0.01 Neg versus RNAi; #P,0.05, ##P,0.01 compared
with Neg control.
(TIF)
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